Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-24-000432
Filing Date
2024-01-23
Accepted
2024-01-23 16:42:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4835
  Complete submission text file 0001959173-24-000432.txt   6492
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-51122 | Film No.: 24553145
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address PDI, INC. 1 ROUTE 17 SOUTH SADDLE RIVER NJ 07458
Business Address
Lurker Nancy (Reporting) CIK: 0001450485 (see all company filings)

Type: 144